Products and preclinical contract research (CRO) for inflammation, neurology, cardiovascular and pain. Our approach is one of complete flexibility. Test items can be evaluated as a strategic and systematic process or as a stand alone service depending on where in the development phase a test item is. MD Biosciences staff can operate as an external research group for the client, capable of initiating ideas, proposing projects, bringing insight and observations We provide a customized, efficient and systematic approach to discovery aimed at reducing late phase failures.
Services capabilities: - in vitro screening for compound profiling studies - in vivo and in vitro mechanism of action platforms for therapeutic targeting or repositioning strategies - Efficacy and proof-of-concept studies - Biomarker and gene expression analysis - Imaging capabilities - Histology and IHC analysis
Products include: - Disease induction reagents - ELISA and assay kits - Proteins and Antibodies
AAIPharma Services Corp. is a leading provider of services that encompass the entire pharmaceutical drug development process from early development through commercialization. The company, which has the benefit of more than 30 years of experience, specializes in analytical chemistry, formulation...
Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients worldwide.